Journals / Toraks Dergisi / 2003 / Cilt: 4 - Sayı: 2

Effect of asbestos body content in bronchoalveolar lavage fluid on pulmonary function tests in occupationbal exposure to asbestos

Mesleksel asbest maruziyetinde bronkoalveoler lavaj sıvısındaki asbest cisimciği içeriğinin solunum fonksiyon testlerine etkisi

Pages
173–178
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We concluded that in patients with short exposure duration, the number of asbestos bodies in BAL fluid did not have influence on PFT, but presence of asbestos bodies in BAL fluid could show exposure to asbestos.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, we aimed to investigate the effect of asbestos body (AB) content in bronchoalveolar lavage (BAL) fluid on pulmonary function tests (PFT) among workers of a brake lining factory.
📊
Key Findings & Data:Out of 288 workers that PFT and DLCO were performed during the investigation in the factory, 34 workers with DLCO <80% were enrolled.
💡
Conclusion & Impact:We concluded that in patients with short exposure duration, the number of asbestos bodies in BAL fluid did not have influence on PFT, but presence of asbestos bodies in BAL fluid could show exposure to asbestos.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Bronkoalveolar lavaj sıvısı · Asbest · Solunum fonksiyon testleri

Abstract

In this study, we aimed to investigate the effect of asbestos body (AB) content in bronchoalveolar lavage (BAL) fluid on pulmonary function tests (PFT) among workers of a brake lining factory. Out of 288 workers that PFT and DLCO were performed during the investigation in the factory, 34 workers with DLCO <80% were enrolled. All the workers had PFT and DLCO measurements and cellular analysis, also AB and asbestos fibers in BAL fluid were evaluated. Mean age and mean number of years at work among 34 workers were 36.5 years (±6.3) and 8.8 years (±4.9), respectively. Fourteen (41.2%) of them had AB in their BAL fluid, and the mean number of AB per mL was 2.5 (±6.3). PFT and BAL results of the workers with AB positive in BAL were FEV1: 101.6% (±12.6), FVC: 102.2% (±11.2), FEVCO/FVC: 100.5% (±8.5), Vmax50: 89.4% (±31.4), Vmax25: 67.8% (±28.3), DLCO: 53.9% (±15), DLCO/VA: 39.9% (±11.5); mean percent of alveolar macrophages in BAL fluid were: 85.8% (±6.7), lymphocytes: 6.3% (±3.9), PNL: 6.9% (±3.6), and eosinophils: 1.5% (±1). PFT and BAL results of the workers with AB negative in BAL were FEV1: 97.4% (±14), FVC: 96.9% (±11.1), FEV1/FVC: 101.3% (±7.9), Vmax50: 82.8% (±21.9), Vmax25: 68% (±26), DLCO: 60.3% (±8), DLCO/VA: 48.5% (±14.4); mean percent of alveolar macrophages in BAL fluid were: 80.3% (±8.6), lymphocytes: 8.7% (±8), PNL: 9% (±5.2), and eosinophils: 1.6% (±1.1). When 14 subjects with asbestos bodies in BAL fluid were compared with 20 subjects without asbestos bodies, no significant difference was found in FEV1, FVC, FEV1/FVC, Vmax50, Vmax25, DLCO, DLCO/VA but the number of asbestos fibers was significantly higher in the group with asbestos bodies in BAL fluid. We concluded that in patients with short exposure duration, the number of asbestos bodies in BAL fluid did not have influence on PFT, but presence of asbestos bodies in BAL fluid could show exposure to asbestos.

Özet

Bu çalışmada fren balatası üreten bir fabrikada çalışan işçilerde bronkoalveoler lavaj (BAL) sıvısındaki asbest cisimciği (AC) miktarının solunum fonksiyon testleri (SFT) üzerindeki etkisinin araştırılması amaçlanmıştır. Çalışmaya fabrika taraması sırasında SFT ve DLCO yapılan 288 işçiden DLCO <%80 olan 34 işçi alınarak, BAL sıvısında hücre analizi, asbest cisimciği ve asbest lifi incelemesi yapılmıştır. Yaş ortalaması 36.5 (±6.3) ve ortalama çalışma süresi 8.8 (±4.9) yıl olan 34 işçinin 14'ünde (%41.2) BAL sıvısında AC saptanmış ve ortalama AC/mL sayısı 2.5 (±6.3) bulunmuştur. BAL'da AC (+) olan grupta ortalama FEV1: %101.6 (±12.6), FVC: %102.2 (±11.2), FEV1/FVC: %100.5 (±8.5), Vmax50: %89.4 (±31.4), Vmax25: %67.8 (±28.3), DLCO: %53.9 (±15), DLCO/VA: %39.9 (±11.5); BAL'da ortalama alveoler makrofaj: %85.8 (±6.7), lenfosit: %6.3 (±3.9), PNL: %6.9 (±3.6), eozinofil: %1.5 (±1) bulunmuştur. BAL'da AC (-) olan grupta ise ortalama FEV1: %97.4 (±14), FVC: %96.9 (±11.1), FEV1/FVC: %101.3 (±7.9), Vmax50: %82.8 (±21.9), Vmax25: %68 (±26), DLCO: %60.3 (±8), DLCO/VA: %48.5 (±14.4); BAL'da ortalama alveoler makrofaj: %80.3 (±8.6), lenfosit: %8.7 (±8), PNL: %9 (±5.2), eozinofil: %1.6 (±1.1) olarak saptanmıştır. BAL'da AC saptanan 14 olgu ile saptanmayan 20 olgu karşılaştırıldığında FEV1, FVC, FEV1/FVC, Vmax50, Vmax25, DLCO, DLCO/VA ve BAL'ın hücresel dağılımı açısından gruplar arasında istatistiksel olarak anlamlı fark saptanmamış, ancak BAL'da AC saptanan grupta asbest lifi sayısı diğer gruptan anlamlı olarak yüksek bulunmuştur. Sonuç olarak, asbeste kısa süre maruz kalan olgularda BAL'daki AC miktarının SFT'ye etkisinin olmadığı, ancak BAL'da AC saptanmasının maruz kalmayı göstermede yararlı olabileceği düşünülmüştür.

🔖

Cite This Article

ÇOK, G., ERDİNÇ, M., BALIM, Z., ERDİNÇ, E., TOPÇUOĞLU, N. (2003). Effect of asbestos body content in bronchoalveolar lavage fluid on pulmonary function tests in occupationbal exposure to asbestos. Toraks Dergisi, Cilt: 4 - Sayı: 2, 173–178. https://ajindex.com/articles/367999

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. De Vuyst P, Karjalainen A, Dumortier P, et al. Guidelines for mineral fibre analyses in biological samples: report of the ERS Working Group. Eur Respir J 1998
  2. 1426 2) Sebastian P, Armstrong B, Monchaux G, et al. Asbestos bodies in bronchoalveolar lavage fluid and in lung parenchyma. Am Rev Respir Dis 1988
  3. 8 3) De Vuyst P, Dumortier P, Moulin E, et al. Diagnostic value of asbestos bodies in bronchoalveolar lavage fluid. Am Rev Respir Dis 1987
  4. 136 (5): 1219-1224 4) Miller A, Lilis R, Godbold J, et al. Relationship of pulmonary function to radiographic interstitial fibrosis in 2611 long-term asbestos insulators. Am Rev Respir Dis 1992
  5. Sue DY, Oren A, Hansen JA, et al. Lung function and exercise performance in smoking and nonsmoking asbestos-exposed workers. Am Rev Respir Dis 1985
  6. American Thoracic Society (ATS), Standardization of spirometry. Am Rev Respir Dis 1987
  7. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique 1995 update. Am J Respir Crit Care Med 1995
  8. Erdinc M, Erdinc E, Cok G, et al. Respiratory impairment due to asbestos exposure in brake-lining workers. Environmental Research 2003
  9. Karjalainen A, Piipari R, Mantyla T, et al. Asbestos bodies in bronchoalveolar lavage in relation to asbestos bodies and asbestos fibers in lung parenchyma. Eur Respir J 1996
  10. 9(5): 1000-1005. 10) Fraser RS, Müller NL, Colman N, et al. Inhalation of inorganic dust (pneumoconiosis). In: Fraser RS, Müller NL, eds. Diagnosis of Diseases of the Chest. 4th ed. Philadelphia, 1999
  11. Polatlı M, Balım Z, Erdinç E ve ark. Asbest maruziyetinde BAL sıvısında asbest cisimcikleri ve hücre dağılımı. Solunum 1995
  12. Schwartz DA, Galvin JR, Burmeister LF, et al. The clinical utility and reliability of asbestos bodies in bronchoalveolar fluid. Am Rev Respir Dis 1991
  13. Garcia JGN, Friffith DE, Cohen AB, et al. Alveolar macrophages from patient with asbestos exposure release increased levels of leukotriene B4. Am Rev Respir Dis 1989
  14. Robinson BW, Rose AH, James A, et al. Alveolitis of pulmonary asbestosis: Bronchoalveolar lavage studies in crocidolite-and chrysotile- exposed individuals. Chest 1986
  15. Xaubet A, Rodriguez-Roisin R, Bombi JA, et al. Correlation of bronchoalveolar lavage and clinical and functional findings in